FDA Clearance Tracker · K231086
CPM System
Last checked: Nov 20, 2026Latest source record: Dec 22, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Dec 22, 2023
Substantially Equivalent
Time to decision
249 days
Received Apr 17, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K231086
- Device name
- CPM System
- Applicant
- Analog Devices, Inc.
- Applicant location
- Wilmington, MA
- Received
- Apr 17, 2023
- Decided
- Dec 22, 2023
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.2300
- Specialty
- CardiologyElectrophysiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MWI. The earliest in FDA's data is K980688, decided Mar 16, 1999.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K231086
- The applicant filed a statement instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Analog Devices, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.